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HIV-1 Nef protein has been known to induce downmodulation of CD4 receptor. In order to test whether the two proteins
physically interact, the yeast two-hybrid system was exploited. A Saccharomyces cerevisiae strain carrying a GAL4-respon-
sive lacZ fusion gene was cotransformed with plasmids in which the Nef and the CD4 cytoplasmic domain (CD4cd) coding
sequences were fused to either the DNA binding (DB) or the activation (A) moiety of the GAL4 transcriptional activator.
Both the DB-Nef / A-CD4cd and the DB-CD4cd / A-Nef combinations activated the reporter gene, weakly but specifically,
as inferred by comparison with a number of controls. Reporter activation was similarly observed when DB-Nef was cotrans-
fected with the fusion A-CD4cd(aa 1–23). On the contrary, the combination DB-Nef / A-CD4cd(aa 24–40) was inactive.
Also, mutating the CD4cd Leu20 –Leu21 motif (known to be essential for both physiological and Nef-induced CD4 endocytosis)
to Ala20 –Ala21 abolished the GAL4 activity of DB-Nef / A-CD4cd. None of six DB-Nef derivatives in which Nef was partially
deleted activated specifically the reporter when coexpressed with A-CD4cd. These findings suggest that CD4cd and Nef
directly interact and that a largely complete Nef is required for the interaction. CD4cd aa 1–23 are sufficient for binding;
in particular, the Leu20 –Leu21 motif is essential. One can infer from these data that: (i) Nef-induced CD4 downmodulation
involves a direct CD4–Nef contact and (ii) CD4cd Leu20 –Leu21 is required in Nef-induced downmodulation, not simply as
an endocytosis signal, but also as an essential component of the Nef-binding moiety. q 1996 Academic Press, Inc.
Like other retroviruses, HIV-1 deploys a specific strat- cytoplasmic domain (cd) (10, 11), which in helper T-cells
is normally bound to protein–tyrosine kinase Lck (12).egy to confer superinfection immunity on infected cells.
As Nef-induced CD4 downmodulation takes place alsoThree HIV-1 gene products are involved in cell surface
in Lck0 cells, CD4–Lck interaction is not necessary fordownmodulation of CD4, a transmembrane glycoprotein
Nef effect; on the other hand, CD4–Lck dissociation isassociated to T-cell receptor and used by HIV-1 as a
an obliged early step in CD4 endocytosis (13, 14). Criticalreceptor (1, 2). This functional convergence of HIV-1 pro-
for Nef effect is the preservation of the CD4cd hydropho-teins suggests that forcing CD4 disappearance from the
bic cluster with propensity to form an a-helix (11, 14; Fig.cell surface is crucial in HIV-1 life cycle. Vpu and gp 160,
1A), in particular of the dileucine (Leu–Leu) motif whichwhich act coordinately, are expressed late in infection
is also essential for physiological CD4 endocytosis (11,and retain CD4 in the endoplasmic reticulum, blocking
15). On the contrary, cd serines, whose phosphorylationCD4 transport to the cell surface and inducing its degra-
by protein kinase C triggers CD4 endocytosis in phorboldation (3– 6). Nef, on the contrary, is an early-expressed
esters-stimulated T-cells, are not essential (11). Similarly,protein and causes downregulation by promoting CD4
two cysteines (Fig. 1A) implicated in CD4cd associationendocytosis, while leaving CD4 synthesis and transport
with Lck (12) are dispensable for the responsiveness toto the cell surface unaffected (reviewed in 7–9). Other
Nef (10, 11, 13). A full downmodulation effect requiresknown effects of Nef are the positive/negative influence
that Nef is myristylated (16, 11), i.e., that it associates toon transcription of HIV-1 LTR and some cell promoters
membranes, while the Nef proline-rich domain (Fig. 1B),and the enhancement of HIV-1 infectivity (7–9). Failure
which might mediate Nef interaction with the SH3 do-to confirm some of the mentioned Nef properties in a
main of Lck or related kinases (17, 18), and is essentialnumber of reports seems to be in part explained by allelic
for infectivity enhancement (19), seems to be dispens-variation in Nef effects and by the nature of the host cell.
able (17, 19). A relevant question is whether downregula-There is agreement, however, on the notion that Nef is
tion involves a direct interaction between Nef and CD4cd.required for pathogenicity in vivo of HIV-1 and of its sim-
As copurification approaches failed to demonstrateian relative SIV.
CD4–Nef association in HIV-1-infected human cells, as-Nef-induced CD4 downmodulation is mediated by CD4
sociation, if present, in the natural context must be weak
and/or transient.
Here, to address the issue of CD4–Nef interaction, we1 To whom correspondence and reprint requests should be ad-
dressed. resorted to a sensitive assay which reveals even elusive
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FIG. 1. CD4 cytoplasmic domain (CD4cd), Nef full-length sequences, and deletion/point mutants analyzed in this work. (A) CD4cd (top). The N-
terminal portion essential for Nef-induced downmodulation is underlined; in bold face, the Leu–Leu motif crucial for both physiological and Nef-
induced endocytosis and the cysteines thought to mediate CD4-Lck interaction; a, putative a-helix extension. wt CD4cd coding sequence and
deleted variants (CD4cd1–23 and CD4cd24–40; center) were amplified from CD4 cDNA by use of the primers (the CD4-annealing portions are underlined):
1. 5*-GAGATCGAATTCTGTGTCAGGTGCCGGCACCG
2. 5*-GAGATCGAATTCTGAAGAAGACCTGCCAG
3. 5*-AGGCCTCTGCAGTCACTCACTGAGGAGTCTC
4. 5*-AGGCCTCTGCAGGCCTCAAATGGGGCTACATG
Primers were combined as follows: 1 / 4 (CD4cd); 1 / 3 (CD4cd1–23); 2 / 4 (CD4cd24–40). To create CD4cdAla–Ala mutant (center), the partially
complementary primers (the CD4-annealing portions are underlined; the complementary sequences are in bold face):
5. 5*-CTCACTGGCGGCTCTCTTGATCTG
6. 5*-AAGAGAGCCGCCAGTGAGAAGAAG
were combined with 1 and 4, respectively, for first-round amplifications; intermediate amplification products were merged by use of the external
primers 1 and 4. The amplified DNA was restricted with EcoRI / PstI and cloned into the corresponding sites of either pGBT9 or pGAD424 plasmids
(Clontech). Bottom, sequences from a screening for Nef-binding protein genes, performed with the YTHS (bait, pGBT9-Nef; library, human liver
cDNAs cloned into pGAD10, a GAL4-A expression plasmid similar to pGAD424). The sequences are aligned at the Leu–Leu motif in a charged
context, a putative Nef-binding consensus. (B) Nef structure. The N-terminal myristic acid adduct (myr) linked to Gly2, a protein kinase C site (Thr15;
circled P), the SH3-binding motif (aa 69–78), and a putative G-protein homology (aa 95–111) are depicted (top). The precise fusion of Nef coding
sequence to GAL4 sequences was obtained by amplifying HIV-1 cDNA (BH10) with the primer pair:
5*-TCGCCGGAATTCGGTGGCAAGTGGTCAAAAAGTAGT (forward);
5*-ACGCCTCTGCAGTCAGCAGTTCTTGAAGTACTCCGGA (reverse).
The amplification product was restricted with EcoRI / PstI and inserted into either pGBT9 or pGAD424. Six nef deletion derivatives (bottom) were
generated by restriction of the full-length insert and cloned into pGAD424.
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protein–protein contacts, the yeast two-hybrid system pressing wt GAL4 were dark blue. Similarly, double trans-
formants synthesizing DB and A fused to protein frag-(YTHS; 20). This exploits the properties of Saccharo-
myces cerevisiae GAL4 transcriptional activator. GAL4 ments unrelated to Nef and CD4 and known to interact
(DB-p53 amino acids 72–390 vs A-SV40 TAg amino acidshas two functional domains which are independent and
physically separable in the linear sequence of the pro- 84–708) were intensely stained (Fig. 2).
Coexpression of Nef and CD4cd, fused to complemen-tein. The DNA-binding (DB) domain binds specifically a
sequence in GAL4-responsive upstream activating se- tary GAL4 domains, generated blue colonies, although
less intensely stained than those seen with yeast trans-quences. The activator (A) domain interacts with the tran-
scriptional machinery. To promote transcription of re- formed with positive controls (Fig. 2). Only white colonies,
on the contrary, were observed after transformation withsponsive genes, GAL4 DB and A must be kept in spatial
proximity. In YTHS, a strain of S. cerevisiae with an inte- either of the plasmids encoding DB alone or A alone or
with the two in combination. Similarly, only white coloniesgrated copy of a GAL4-responsive reporter gene provides
the readout of GAL4 activity. The host is transformed were formed by cells expressing individually DB-Nef, A-
Nef, DB-CD4cd, or A-CD4cd (Fig. 2) or combinations ofwith two plasmids coding for GAL4 fusion proteins. One
plasmid encodes a fusion of DB and protein X, while the one of them with DB, DB-p53, A, or A-SV40 TAg.
In order to quantify b-gal synthesis, individual clonesother encodes a fusion of A and protein Y. If X and Y
interact, DB and A are brought together, thus activating were grown in liquid culture. Crude cell extracts were
assayed for b-gal, using o-nitrophenyl-b-D-galactopyra-the reporter gene. Genuine interactions are expected to
activate the reporter regardless of whether each partner noside (ONPG) as a substrate, and for total protein. The
results (Table 1) reflected those obtained with the plateis fused to DB or to A. In contrast, X or Y fusions should
not activate when expressed alone, nor when expressed screen. A baseline b-gal activity was found in all trans-
formants except those harboring the combinations oftogether with DB or A, which are either unfused or fused
to unrelated polypeptides (21). plasmids expressing DB-Nef / A-CD4cd and DB-CD4cd
/ A-Nef and the positive controls producing wt GAL4 orIn our work, the nef gene (BH10 strain) was fused to
either the GAL4-DB coding region or the GAL4-A coding the combination DB-p53 / A-SV40 TAg. The activity in
cells synthesizing DB-Nef / A-CD4cd and DB-CD4cd /region, in the context of yeast expression vectors se-
lectable by the TRP1 or LEU2 marker, respectively. The A-Nef was similar, one order of magnitude lower than
that in GAL4 control.nef allele used here has been shown to exhibit CD4
downmodulation. Fusions were designed to attach nef The above results support the hypothesis that HIV-1
Nef and CD4cd physically interact. The weakness of thecodon 2 (Gly-2) C-terminally to DB or A coding regions.
Nef Gly-2 is the substrate of myristylation in the natural observed activation in YTHS might reflect the weak or
transient nature of Nef–CD4cd interaction, althoughprotein (Fig. 1B); in GAL4–Nef fusions it assumes an
internal position and cannot be myristylated. In parallel, other factors may exert some influence, e.g., a partial
steric hindrance by the fused Gal4 domains or a lowthe segment of CD4 gene (22) coding for the 40 amino
acid cytoplasmic domain (Fig. 1A) was fused down- stability of either hybrid protein.
Then we attempted to define which portions of CD4cdstream to, and in frame with, either DB or A coding re-
gions, in the same vectors used for Nef. and Nef are involved in the interaction. Gene fragments
coding for CD4-cd 1–23 or 24–40 were fused to the AS. cerevisiae SFY526 (trp1-901, leu2-3, gal4-542, UR-
A3: :GAL1-lacZ), carrying a GAL4-responsive lacZ fusion coding sequence instead of the entire domain (Fig. 1A).
A-CD4cd1 – 23, when coexpressed with DB-Nef, activatedgene, was transformed with combinations of Nef- and
CD4cd-expressing plasmids (DB-Nef / A-CD4cd; DB- the reporter gene similarly to the full-length A-CD4cd,
whereas DB-Nef / A-CD4cd24 – 40 were inactive (Table 1).CD4cd / A-Nef). In parallel, individual transformations
with each of the Nef- and CD4cd-expressing plasmids, A Leu20 –Leu21 to Ala20 –Ala21 mutation in CD4cd has
been shown to render the receptor insensitive to the Nef-as well as various single or double transformations in-
cluding control plasmids were performed. Transformants induced downregulation (11). In order to test whether the
Leu20 –Leu21 motif is directly involved in CD4-Nef binding,were selected for prototrophy for leucine, triptophan, or
both. Transformant colonies were then screened for b- an A-CD4cd hybrid with the motif changed to Ala–Ala
(A-CD4cdAla – Ala) was created (Fig. 1A). The CD4cd codinggalactosidase (b-gal) production by replica-plating onto
paper filters. The filters were briefly immersed into liquid sequence was modified by PCR-mediated mutagenesis
to introduce the desired mutation, and the gene fragmentnitrogen, soaked in a buffer containing the 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside (X-gal) substrate was fused 3* to the A coding sequence in the expression
vector. A-CD4cdAla – Ala was then assayed against DB-Nef.and incubated overnight at 307. Under these conditions,
if b-gal is expressed colony replicas turn blue. The mutation was found to strongly depress the interac-
tion: the blue staining became hardly appreciable onThe colony phenotype was found to be reproducible
in repeated experiments, and all colonies on a plate gave plate (Fig. 2), and the b-gal activity in the liquid assay
was reduced to 1/4 relative to that detected with the DB-similar results. Untransformed SFY526 colonies were
white, while all colonies transformed with a plasmid ex- Nef / A-CD4cd cross, slightly over the baseline activity
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FIG. 2. Colony phenotype of transformants synthesizing key combinations of GAL4 fusions. Dark colonies indicate a reconstituted GAL4 activity.
(Table 1). These results suggest that the CD4cd se- interaction. The conservation of a complete CD4 cyto-
plasmic tail was not required for binding, as the CD4cdquence critical for Nef binding can be restricted to aa
1–23, and that the dileucine element located distally in fragment spanning residues 1–23 (which include the
Leu–Leu motif) could still bind Nef. In contrast, the con-this stretch is particularly important for the interaction.
Finally, six nef fragments were fused to the DB-coding servation of an intact Nef sequence seems to be indis-
pensable for interaction, as none of a number of N- and/sequence instead of the complete gene (Fig. 1B). Only
one of these DB fusions activated the reporter in combi- or C-terminal Nef deletion mutants displayed specific
CD4cd binding.nation with A-CD4cd. The putative binding-competent fu-
sion, however, was found to activate the reporter even Harris and Neil (24) have previously shown that CD4
can be copurified with a Nef-glutathione S-transferasealone, which suggests that it behaves like a spurious
activator protein in yeast (Table 1). chimera when these proteins are expressed together in
insect cells via baculovirus vectors. However, the indica-In summary, Nef protein was shown to interact with
CD4 cytoplasmic tail in YTHS. The interaction, although tion from those results that Nef and CD4 interact has
been somewhat overlooked in subsequent reports, asweak, was specific, as indicated by a number of controls.
The dileucine motif within CD4cd was shown to be criti- the overexpression of the putative partners and the in-
ability of insect cells to endocytose CD4 did not permitcal for Nef binding, as its mutation almost abolished
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TABLE 1
Plate Phenotype and b-gal Activity in Saccharomyces cerevisiae SFY526 Cells Transformed with GAL4-DB and GAL4-A Expression Plasmids
Plasmid
b-gal activity (converted
GAL4-DB (TRP1) GAL4-A (LEU2) Blue phenotype ONPG nmols 1 min01 1 mg01)
pCL1 (wtGAL4) // nt
pVA3 (p53 aa72–390) pTD1 (TAg aa84–708) // 5.75
pGBT9 pGAD424 0 0.12
pGBT9-Nef None 0 0.11
pGBT9-Nef pGAD424 0 0.12
pGBT9-Nef pGAD424-CD4cd / 0.54
pGBT9-Nef pTD1 0 0.15
None pGAD424-CD4cd 0 0.11
pGBT9 pGAD424-CD4cd 0 0.10
pVA3 pGAD424-CD4cd 0 0.11
pGBT9-CD4cd None 0 0.12
pGBT9-CD4cd pGAD424 0 0.11
pGBT9-CD4cd pGAD424-Nef / 0.55
pGBT9-CD4cd pTD1 0 0.10
None pGAD424-Nef 0 0.11
pGBT9 pGAD424-Nef 0 0.11
pVA3 pGAD424-Nef 0 0.12
pGBT9-Nef pGAD424-CD4cd1–23 / 0.53
pGBT9-Nef pGAD424-CD4cd24–40 0 0.10
pGBT9-Nef pGAD424-CD4cdAla–Ala 0 0.17
pGBT9-NefD1 pGAD424-CD4cd 0 nt
pGBT9-NefD2 pGAD424-CD4cd 0 nt
pGBT9-NefD3 pGAD424-CD4cd 0 nt
pGBT9-NefD4 pGAD424-CD4cd / nt
pGBT9-NefD4 None / nt
pGBT9-NefD4 pGAD424 / nt
pGBT9-NefD5 pGAD424-CD4cd 0 nt
pGBT9-NefD6 pGAD424-CD4cd 0 nt
Note. Yeast cells were transformed with the indicated plasmids, following the lithium acetate method. Cells were plated onto SD synthetic
medium-agar plates, lacking the selection amino acids. After 4 days at 307, colonies were replica-plated onto paper filters. These were dipped into
liquid nitrogen, soaked in X-gal buffer, and incubated at 307. Alternatively, single colonies were reinoculated into liquid SD-selection medium and
shaken at 307 overnight. Cells were lysed for soluble protein extraction according to the vortexing-glass beads method. All the above procedures
followed Clontech Matchmaker kit protocols. Total protein was assayed with the BCA reagent (Pierce) and b-gal assayed after Ausubel et al. (23).
b-gal activity was calculated using the following equation:
b-gal activity  OD420 1 1.7/0.0045 1 t01min 1 vol01(ml) 1 [protein](mg/ml)
The reported activity values are the average of at least three colonies from at least two independent transformations.
to rule out an artifact (8). Altogether, the YTHS-based pered, or YTHS, which genetically amplifies transient pro-
tein–protein contacts.results presented here and the earlier results in the in-
sect cell/baculovirus system corroborate each other, ren- Since in our yeast experiments the CD4–Nef associa-
tion takes place in an artificial context—inside the nu-dering experimental evidence for a physical interaction
between Nef and the cytoplasmic tail of CD4 more con- cleus, with both the interacting elements fused C-termi-
nally to yeast GAL4 domains, and devoid of the moietiesvincing. It is worth stressing that the demonstration of
Vpu–CD4 interaction has proven similarly difficult. In that that target them to cell membranes—it appears that Nef
N-terminal myristylation is not an absolute requirementcase, the CD4 exodomain and transmembrane domain
were replaced by the CD8 counterparts; this, by slowing for the interaction per se and that its function with respect
to CD4 binding could be as a membrane targeting signaldown dissociation and/or degradation, allowed to copre-
cipitate the partners (25). One might speculate that Nef only. The maintenance of a largely intact tertiary structure
of Nef, on the other hand, seems highly important for theadopts an analogous ‘‘touch-and-run’’ strategy in CD4cd
recognition, quickly releasing its prey, e.g., transferring interaction. This suggests that the Nef surface involved in
CD4cd binding is assembled from amino acids distantlyit to the endocytic machinery (see below). The transient
Nef–CD4 complex would be consequently captured only located along the linear sequence.
More interestingly, the minimal CD4cd portion involvedin heterologous host cell systems, like baculovirus-in-
fected insect cells, where receptor endocytosis is ham- in Nef binding coincides with that mediating the respon-
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FIG. 3. Hypothetical scheme of Nef action. In the absence of protein–tyrosine kinase Lck bound to CD4cd (A), Nef is targeted to the membrane-
proximal portion of CD4cd and alters the conformation of the latter by unmasking and binding the hydrophobic box. In Lck/ cells (B), Nef is targeted
to CD4cd–Lck complexes, recognized with increased avidity thanks to the double affinity for CD4cd hydrophobic box and Lck SH3 domain; Lck is
subsequently displaced from CD4 and possibly triggers an intracellular signaling cascade. In both A and B, Nef eventually induces CD4 transport
to clathrin-coated pits and endocytosis.
siveness to Nef-induced downmodulation (10, 11, 13, 14); which overlaps the Nef-binding moiety would trigger CD4
internalization (Fig. 3A). When CD4 is complexed tothere is also the identical requirement, in both interaction
and downmodulation, for CD4cd Leu20 –Leu21 motif (11). Lck—the physiological setting in lymphocytes—Nef
might recognize the complex with increased avidity,It is tempting, thus, to speculate that the role of the mem-
brane-proximal portion of CD4cd in Nef-induced down- thanks to its affinity for both components, determining
Lck detachment and CD4 endocytosis (Fig. 3B). Themodulation is not simply as an endocytosis signal, but
that it is involved also in Nef recognition. A fortuitous model helps to rationalize the observation that Lck pres-
ence is not necessary for Nef-induced endocytosis, butobservation further supports this view. In the course of
a screening for genes encoding Nef-binding proteins, enhances it (13). An implication of this model is also that
Nef–CD4 contacts are productive for the CD4 downmod-performed by coespressing the DBD–Nef fusion as a
bait in YTHS, seven clones were recovered from a GAL4 ulation only at the cell surface; interactions which may
take place at intracellular membranes would not affectA–liver cDNA fusion library. Although all of the clones
passed the tests for false-positivity exclusion, the cDNAs receptor anterograde transport.
were found to be inserted out-of-frame or antisense with
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